Oxford, UK, Philadelphia, PA, 3rd May 2011: Bridging radiology and radiation oncology, innovative RT workflows developed by Mirada Medical Limited are the latest in Mirada's portfolio of oncology products on display at the European Society for Therapeutic Radiology and Oncology (ESTRO) Anniversary Conference, London UK 8th-11th May 2011.
New RT workflows in XD3, Mirada's multi-modality and multi-timepoint oncology software, harness the power of CT-CT registration between the planning CT and PET/CT to provide functional imaging information for target delineation with accuracy and speed. XD3's registration engine also performs tri-modal fusion between PET/CT and MR in order to immediately realise the benefits of PET-MR for treatment planning, without having a PET-MR scanner. This software-based PET-MR presents powerful information during tumour assessment, staging, and delineation, with better visualisation of soft tissue abnormalities and tumours best localised using MR, such as lymph nodes in the neck.
Central to XD3 is the ability to assess, quantify and compare patient studies across unlimited timepoints, in custom display layouts, simultaneously. Through registration, users can easily propagate VOIs across timepoints, creating tables and graphs which track quantification statistics for comparison and reporting. Statistics are configurable for each user and include PERCIST, RECIST, WHO, among others.
source: Mirada Medical
Saturday, May 7, 2011
Mirada Medical develops radiation therapy workflows for multidisciplinary cancer management
Posted by Rad at 11:42 AM
Subscribe to:
Post Comments (Atom)
1 comment:
Nice work done... You have shared very good information..
Skin cancer is the most prevalent of all types of cancers. However, various methods of skin cancer treatment have emerged to eradicate this disease. You can visit Skin Cancer Treatment in Alabama to get detailed information
Post a Comment